Publications (2018)

Publication (International journal)

1. Tanabe S, Kutsuna S, Tsuboi M, Takeshita N, Hayakawa K, Ohmagari N.
   Meningoencephalitis Caused by a Campylobacter fetus in a Patient with Chronic Alcoholism.
   Intern Med. Mar, 2019.
2. Fujiya Y, Hayakawa K, Gu Y, Yamamoto K, Mawatari M, Kutsuna S, Takeshita N, Kato Y, Kanagawa S, Ohmagari N.
   Age-related differences in clinical characteristics of invasive group G streptococcal infection: Comparison with group A and group B streptococcal infections.
   PLoS One. 14(3), Mar, 2019.
3. Ujihara T, Yamamoto K, Kitaura T, Katanami Y, Kutsuna S, Takeshita N, Hayakawa K, Ohmagari N.
   A Case of Calcium Pyrophosphate Deposition Disease Involving a Lumbar Facet Joint Following Urinary Tract Infection.
   Intern Med. Feb, 2019.
4. Inagaki A, Moriyama Y, Morioka S, Wakimoto Y, Shida Y, Ohmagari N.
   A case of Klebsiella pneumoniae spondylitis and bacteremia potentially due to inflammation around a fecalith.
   J Infect Chemother. Feb, 2019.
5. Ujiie M, Terada M, Kobayakawa M, Ohmagari N.
   Clinical Trial with unlicensed yellow fever vaccine in Japan.
   J Travel Med. Jan, 2019.
6. Moriyama Y, Ishikane M, Hayakawa K, Yamamoto K, Akazawa T, Sugiki Y, Ohmagari N.
   Comparison of knowledge to antimicrobial stewardship institution policies targeting Staphylococcus aureus bacteremia and candidemia between medical doctors and pharmacists in an academic teaching hospital in Japan.
   J Infect Chemother. Nov, 2018.
7. Itoh N, Hadano Y, Saito S, Myokai M, Nakamura Y, Kurai H.
   Intravenous to oral switch therapy in cancer patients with catheter-related bloodstream infection due to methicillin-sensitive Staphylococcus aureus: A single-center retrospective observational study.
   PLoS One. 13(11):e0207413, Nov, 2018.
8. Takaya S, Kutsuna S, Kato Y, Ohmagari N.
   Hydrocele due to Wuchereria bancrofti Infection.
   Intern Med. 58(6):897, Mar, 2019.
9. Mawatari M, Kobayashi T, Yamamoto S, Takeshita N, Hayakawa K, Kutsuna S, Ohmagari N, Noguchi T, Kato Y.
   Mild encephalitis/encephalopathy with a reversible splenial lesion due to Plasmodium falciparum malaria: a case report.
   Trop Med Health. 46:37, Nov, 2018.
10. Kinoshita N, Morisaki N, Uda K, Kasai M, Horikoshi Y, Miyairi I.
    Nationwide study of outpatient oral antimicrobial utilization patterns for children in Japan (2013-2016).
    J Infect Chemother. 25(1):22-27, Jan, 2019.
11. Kamata K, Tokuda Y, Gu Y, Ohmagari N, Yanagihara K.
    Public knowledge and perception about antimicrobials and antimicrobial resistance in Japan: A national questionnaire survey in 2017.
    PLoS One. 13(11):e0207017, Nov, 2018.
12. Takeshita N, Anh NQ, Phuong DM, Thanh DV, Thuy PP, Huong MTL, Takahashi M, Ohmagari N.
    Assessment of Bacteremia in a Large Tertiary Care Hospital in Northern Vietnam: a Single-Center Retrospective Surveillance Study.
    Jpn J Infect Dis. 72(2):118-120, Mar, 2019.
13. Tsuboi M, Hayakawa K, Mezaki K, Katanami Y, Yamamoto K, Kutsuna S, Takeshita N, Ohmagari N.
    Comparison of the epidemiology and microbiology of peripheral line- and central line-associated bloodstream infections.
    Am J Infect Control. 47(2):208-210, Feb, 2019.
14. Hayakawa K, Nagashima M, Kanehisa E, Watanabe R, Kunimatsu J, Ohta K, Mutoh Y, Hashimoto T, Katanami Y, Yamamoto K, Kutsuna S, Tayama N, Ohmagari N.
    Real-time PCR investigation of the prevalence of Fusobacterium necrophorum in patients with pharyngitis in Japan.
    J Infect Chemother. 24(12):969-974, Dec, 2018.
15. Takaya S, Kutsuna S, Suzuki T, Komaki-Yasuda K, Kano S, Ohmagari N.
    Case Report: Plasmodium knowlesi Infection with Rhabdomyolysis in a Japanese Traveler to Palawan, the Philippines.
    Am J Trop Med Hyg. 99(4):967-969, Oct, 2018.
16. Matsunaga N, Hayakawa K.
    Estimating the impact of antimicrobial resistance.
    Lancet Glob Health. 6(9):e934-e935, Sep, 2018.
17. Hamasuna R, Le PT, Kutsuna S, Furubayashi K, Matsumoto M, Ohmagari N, Fujimoto N, Matsumoto T, Jensen JS.
    Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains.
    PLoS One. 13(6):e0198355, Jun, 2018.
18. Hayakawa K, Nagashima M, Ohta K, Ohmagari N, Tayama N.
    Fusobacterium necrophorum Subsp. funduliforme in Tonsils from Various Patient Populations in Japan.
    Jpn J Infect Dis. 71(5):365-367, Sep, 2018.
19. Morioka S, Ichikawa M, Mori K, Kurai H.
    Coagulase-negative staphylococcal bacteraemia in cancer patients. Time to positive culture can distinguish bacteraemia from contamination.
    Infect Dis (Lond). 50(9):660-665, Sep, 2018.
20. Kitaura T, Takahashi M, Umeyama T, Takeshita N, Katanami Y, Takaya S, Yamamoto K, Kutsuna S, Hayakawa K, Kato Y, Yamauchi T, Narita Y, Miyazaki Y, Ohmagari N.
    Cryptococcus gattii genotype VGIIa infection imported from Vancouver Island to Japan.
    J Infect Chemother. 24(7):573-575, Jul, 2018.
21. Katanami Y, Hayakawa K, Shimazaki T, Sugiki Y, Takaya S, Yamamoto K, Kutsuna S, Kato Y, Ohmagari N.
    Adherence to contact precautions by different types of healthcare workers through video monitoring in a tertiary hospital.
    J Hosp Infect. 100(1):70-75, Sep, 2018.
22. Yamamoto K, Ohmagari N.
    Infective Endarteritis due to Staphylococcus capitis.
    Intern Med. 57(8):1185, Apr, 2018.
23. Yamasaki D, Tanabe M, Muraki Y, Kato G, Ohmagari N, Yagi T.
    The first report of Japanese antimicrobial use measured by national database based on health insurance claims data (2011-2013): comparison with sales data, and trend analysis stratified by antimicrobial category and age group.
    Infection. 46(2):207-214, Apr, 2018.
24. Yamamoto S, Gu Y, Fujitomo Y, Kanai N, Yamahata Y, Saito H, Hashimoto T, Ohmagari N
    Development and efficacy of a clinician-targeted refresher course for treating nonpneumonia respiratory tract infections.
    J Gen Fam Med. 19(4):127-132, Jun, 2018.
25. Kutsuna S, Nagashima M, Takaya S, Yamamoto K, Takeshita N, Hayakawa K, Kato Y, Kanagawa S, Ohmagari N
    Wohlfahrtiimonas chitiniclastica Bacteremia Hospitalized Homeless Man with Squamous Cell Carcinoma.
    Emerg Infect Dis. 24(9):1746-1748, Sep, 2018.
26. Shoji K , Funaki T, Fukuda A, Sakamoto S, Kasahara M, Miyairi I
    Safety of BCG Vaccination in Pediatric Liver Transplant Recipients
    Transplantation. 102(4):124-124, Apr, 2018.
27. Miyairi I, Michihata N, Morisaki N, Kinoshita N, Urayama KY, Yasunaga H.
    Recent Prescription Patterns for Children With Acute Infectious Diarrhea.
    J Pesiatr Gastroenterol Nutr. 68(1):13-16, Jan, 2019.
28. Watanuki S, Sada R, Ishikane M, Shimizu T, Kutsuna S.
    The Tokyo GIM Conference: Clinical reasoning conference from real cases.
    J Gen Fam Med. 19(6):228, Sep, 2018.
29. Suzuki T, Kutsuna S, Tsuboi M, Ota M, Hayakawa K, Ohmagari N
    Helicobacter cinaedi Hepatic Cyst Infection with Bacteremia.
    Emerg Infect Dis. 25(3):603-604, Mar, 2019.
30. Tsuyoshi Kitaura, Masamichi Takahashi, Takashi Umeyama, Nozomi Takeshita, Yuichi Katanami, Saho Takaya, Kei Yamamoto, Satoshi Kutsuna, Hayakawa K, Yasuyuki Kato, Takahiro Yamauchi, Yoshitaka Narita, Yoshitsugu Miyazaki, Norio Ohmagari.
    Cryptococcus gattii genotype VGIIa infection imported from Vancouver Island to Japan
    Journal of Infection and Chemotherapy. 24(7):573-575, Jan, 2018.

Presentations at International Conferences and Forums

1. Matsunaga N, Hayakawa K, Sakamoto F, Misawa S, Muraki Y, Fujimoto S, Mikamo H, Murakami N, Shibayama K, Yagi T, Yanagihara K, Tajima T, Gu Y, Ohmagari N.
   The useful of RAND-modified Delphi method to determine the components for the national surveillance system to implement antimicrobial resistance action plan in Japan.
   SHEA 2018. Oregon, USA, Apr, 2018.
2. Takaya S, Matsunaga N, Hayakawa K, Moriyama K, Katanami Y, Tajima T, Tanaka C, Kimura Y, Saito S, Kusama Y, Morioka S, Fujitomo Y, Ohmagari N. Surveillance system of healthcare-associated infection in high and upper-middle income countries: A Scoping Review.
   Surveillance system of healthcare-associated infection in high and upper-middle income countries: A Scoping Review.
   ID Week 2018. San Francisco , USA, Oct, 2018.
3. Kinoshita N.
   Nationwide outpatient oral antimicrobial utilization by children in Japan (2013-2016).
   ID Week 2018. San Francisso, CA, USA, Oct, 2018.
4. Kinoshita N.
   Cytomegalovirus infection in pediatric living donor liver transplant recipients that received antithymocyte globulin.
   9th Asian Congress of Pediatric Infectious Diseases. Fukuoka, Japan, Nov, 2018.
5. Moriyama Y.
   Comparison of adherence to antimicrobial stewardship bundles targeting staphylococcus aureus bacteremia and candidemia between medical doctors and pharmacists in an academic teaching hospital in Japan .
   SHEA. Portland, USA, Apr, 2018.
6. Ishikane M.
   Infection Prevention & Control Program in Support of the Asia Pacific Economic Corporation (APEC) 2018 Four-day Infection Prevention and Control Workshop.
   Third Regional Forum of WHO Collaborating Centres in the Western Pacific. Ho Chi Minh City, Vietnam, Nov, 2018.
7. Ishikane M.
   Infection Prevention & Control in Brazil.
   Health and Safery lecture sponsored by Ministry of Foregin Affairs. Curitiba, Brazil, Nov, 2018.
8. Ishikane M.
   Infection Prevention & Control in Brazil.
   Health and Safery lecture sponsored by Ministry of Foregin Affairs. Rio de Janeiro, Brazil, Nov, 2018.
9. Ishikane M.
   Infection Prevention & Control in Cuba.
   Health and Safery lecture sponsored by Ministry of Foregin Affairs. Havana, Cuba, Nov, 2018.
10. Ishikane M.
    Infection Prevention & Control in Venezuela.
    Health and Safery lecture sponsored by Ministry of Foregin Affairs. Caracas, Venezuela, Nov, 2018.
11. Ishikane M, Kusama Y, Tanaka C, Kimura Y, Hayakawa K, Kuwahara T, Ohmagari N.
    Comparison of antimicrobial use between nursing home residents and the general population in Japan.
    The 17th Asia-Pacific Congress of Clinical Microbiology and Infection. Hong Kong, Hong Kong, Aug, 2018.
12. Kusama Y, Ishikane M, Kihara T, Matsunaga N, Hayakawa K, Ohmagari N.
    Changes in prescription trends for antibiotics against Mycoplasma pneumoniae infections in Japan: 2010–2016.
    The 9th Asian Congress of Pediatric Infectious Diseases. Hakata, Japan, 11, 2018.
13. Kusama Y.
    The impact of carbapenem stewarship on the trend of broad spectrum antibiotic use, Clostridium difficile infection and candidaemia.
    The 28th European Congress of Clinical Microbiology and Infectious Diseases. Madrid, Spain, 4, 2018.
14. Kusama Y.
    Regional variation of antimicrobial use in Japan from 2013 to 2016.
    IDWeek 2018. San Francisco, USA, 10, 2018.
15. Kusama Y.
    Changes in prescription trends for antibiotics against Mycoplasma pneumoniae infections in Japan:2008-2016.
    The 9th Asian Congress of pediatric infectious diseases. Hakata, Japan, 11, 2018.
16. Tsuzuki S.
    The recent trend of MRSA surveillance in Japanese health care facilities.
    IMED. Vienna, Austria, 11, 2018.
17. Hayakawa K, Other.
    A multicenter prospective study of clinical and molecular epidemiological analysis of carbapenem-resistant Enterobacteriaceae (CRE) and carbapenemase-producing Enterobacteriaceae (CPE) in Japan.
    ID week. San Francisco, USA, 10, 2018.
18. Saito S.
    Comparison of the clinical outcomes of patients with IMP-type carbapenemase-producing carbapenem-resistant Enterobacteriaceae and carbapenem-sensitive Enterobacteriaceae in Japan.
    IDweek. San Francisco, USA, 10, 2018.
19. Saito S.
    Risk factors for the acquisition of IMP-type carbapenemase-producing carbapenem-resistant Enterobacteriaceae in Japan: A matched case-control study.
    IDweek. San Francisco, USA, 10.